Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has the Cell Viability Assays Market Growth Performance Trended Historically, And What Lies Ahead?#_x000D_
The rise in the market size of cell viability assays has been quick and substantial in the past few years. Estimated to grow from a size of $1.56 billion in 2024, it’s anticipated to reach up to $1.73 billion by 2025, marking a compound annual growth rate (CAGR) of 10.5%. Various factors have been responsible for the historic increase, which include escalated investments in cancer studies, amplified expenditure in the pharmaceutical R&D domain, growth in the biotechnology sector, advancements in cell culture procedures, growing demand for stem cell investigation, rising needs for toxicity evaluation, enhanced use of real-time cell analysis setups, and an increase in the presence of contract research organizations (CROs)._x000D_
_x000D_
The market for cell viability assays is anticipated to experience substantial growth in the near future, expanding to$2.52 billion in 2029 with a compound annual growth rate (CAGR) of 9.9%. The growth observed within the forecast period can be credited to factors such as the rising demand for personalized medication, increased government support for cell-based studies, a greater emphasis on precision medicine and the expansion of stem cell research and applications, along with a heightened availability of automated cell viability analyzers. Additionally, the rise in cases of infectious diseases, an increased emphasis on enhancing assay accuracy and sensitivity, more awareness regarding the advantages of cell viability assays, growth in organ on a chip technologies development, and an increased demand for regenerative medicine also contribute significantly. Future trends to look out for include advancements in high throughput screening, adoption of AI and machine learning, development of real-time monitoring systems, uptake of automated liquid handling systems, expanded multiplex assays for simultaneous cell viability measurement, the use of more sustainable and eco-friendly reagents, the advent of user-friendly assay kits, advancements in electrochemical assays, scalable cell viability assays implementation, and the creation of assays compatible with primary and stem cells._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp_x000D_
_x000D_
#Which Primay Drivers Are Accelerating Growth in the Cell Viability Assays Market?#_x000D_
The cell viability assay market is set to expand due to the rising prominence of cell-based therapeutics. This refers to treatments that utilize living cells to mend or replace damaged tissue, treat diseases and revive regular function. The acceleration of cell-based therapeutics is propelled by advances in biotechnology, a rise in investment towards regenerative medicine, expanding adoption, and acceptance of cell therapies, along with enhancements in cell engineering and manufacturing technologies. Cell viability assays play a vital role in cell-based therapeutics by safeguarding the health, efficacy, and safety of therapeutic cells, consequently enhancing treatment effectiveness and quality control. The American Society of Gene & Cell Therapy, a nonprofit medical and scientific organization based in the U.S reported that 38 trials were launched for non-genetically modified cell therapies in the first quarter of 2023, which is seven more than the last quarter of 2022. Therefore, the burgeoning field of cell-based therapeutics is fueling the expansion of the cell viability assay market._x000D_
_x000D_
#Which Primary Segments of the Cell Viability Assays Market Are Driving Growth and Industry Transformations?#_x000D_
The cell viability assaysmarket covered in this report is segmented – _x000D_
_x000D_
1) By Product: Consumables; Instruments_x000D_
2) By Application: Basic Research; Stem Cell Research; Drug Discovery And Development; Clinical And Diagnostic Applications; Other Applications_x000D_
3) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospital And Diagnostic Laboratories; Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Consumables: Reagents; Kits; Assay Plates (96-Well plates); Microplates _x000D_
2) By Instruments: Spectrophotometers; Fluorometers; Microplate Readers; Flow Cytometers; Imaging Systems_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp_x000D_
_x000D_
#Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Cell Viability Assays Market?# Market?#_x000D_
North America was the largest region in the cell viability assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Which Technological Trends Are Reshaping the Cell Viability Assays Industry Dynamics?#_x000D_
Leader organizations in the cell viability assays market are introducing groundbreaking cell screening technologies to boost precision and expedite drug discovery. These technologies enhance cell viability assays by ensuring high-precision, fast, and high-capacity analysis of cell health and responses, thereby refining experimental conditions and accelerating the establishment of therapeutic strategies. For example, in May 2024, Arralyze, a tech firm based in Germany, unveiled CellShepherd, an advanced platform designed for single-cell analysis. This platform uses proprietary nanowell glass arrays to downsize cell-based assays for realtime monitoring. The independent system provides accurate cell dispensing, co-culture in sterile environments, and imaging using brightfield and fluorescent channels. The AI-based evaluation ensures exact cell counting and tracking. This easy-to-use platform meets the escalating demand for meticulous single-cell study in biomedical and life science use cases._x000D_
_x000D_
#View the full report here:#_x000D_
https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report_x000D_
_x000D_
#What Parameters Are Used to Define the Cell Viability Assays Market?#_x000D_
Cell viability assays are methods used to determine the ability of cells, tissues, or organs to maintain or recover a state of survival. Cell viability assays are used to evaluate the best growth conditions for cells in culture in response to external stimuli, chemicals, and medicinal treatments when determining optimal growth conditions in cell culture._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16014_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Europe +44 7882 955267_x000D_
Asia & Others +44 7882 955267 & +91 8897263534_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model